mRNA vaccines — a new era in vaccinology
2018 · Nature Reviews Drug Discovery · 4,250 citations
https://doi.org/10.1038/nrd.2017.243
D
Drew Weissman
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
376
Papers
38.9K
Citations
86
h-index
237
i10-index
Drew Weissman is an academic researcher from University of Pennsylvania. The author has contributed to research in topics: RNA Interference and Gene Delivery & HIV Research and Treatment & Immunotherapy and Immune Responses. The author has an h-index of 86, co-authored 320 publications.
ORCID: 0000-0002-1501-6510Papers by this author
worksSuppression of RNA Recognition by Toll-like Receptors: The Impact of Nucleoside Modification and the Evolutionary Origin of RNA
2005 · Immunity · 2,527 citations
https://doi.org/10.1016/j.immuni.2005.06.008
Incorporation of Pseudouridine Into mRNA Yields Superior Nonimmunogenic Vector With Increased Translational Capacity and Biological Stability
2008 · Molecular Therapy · 1,763 citations
https://doi.org/10.1038/mt.2008.200
An ionizable lipid toolbox for RNA delivery
2021 · Nature Communications · 545 citations
https://doi.org/10.1038/s41467-021-27493-0
Effect of Mycobacterium tuberculosis on HIV replication. Role of immune activation
1996 · The Journal of Immunology · 497 citations
https://doi.org/10.4049/jimmunol.157.3.1271
Inherited Resistance to HIV-1 Conferred by an Inactivating Mutation in CC Chemokine Receptor 5: Studies in Populations with Contrasting Clinical Phenotypes, Defined Racial Background, and Quantified Risk
1997 · Molecular Medicine · 423 citations
https://doi.org/10.1007/bf03401665
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat